HOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers.
Cambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust
How to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023.
British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.
mRNA vaccine pioneer CureVac N.V. has announced that it will sell US$200m of its common shares in an underwritten public offering.
South Korean Chong Kun Dang Pharm has licenced access to Amsterdam-based Synaffix BVs propietary ADC platform.
A new platform is set to facilitate the exchange of information on the optimisation of the electronic reporting system CTIS.
British researchers have linked higher consumption of ultra-processed foods to an increased risk of developing and dying from cancer.
Asher Biotherapeutics Inc has expanded its manufacturing agreement with Lonza to include the manufacturing of AB248.
Evotec SE and Janssen Biotech Inc have agreed to co-develop targeted immuno-oncological therapies.